FOLEY HOAG LLP for GILEAD SCIENCES INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy & Commerce 21st Century Cures initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL KIM | — |
Medicare/Medicaid MMM
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy & Commerce 21st Century Cures initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL KIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.